April 14, 2017

See How Design Influences Patient Care in Interactive Washington Post Tour of New Cancer Center

360 tours include radiation and infusion suites


Tour the New Cancer Center with Washington Post

An interactive media experience with Washington Post shows how the new Cleveland Clinic Cancer Center maximizes multidisciplinary care and prioritizes the patient experience. See Brian Bolwell, MD, Chairman, Cleveland Clinic Taussig Cancer Institute, discuss why proximity matters in enhancing the function of a multidisciplinary team, and how architects, patients and physicians designed the new building to facilitate team-based care. Also hear from John Suh, MD, Chair of Radiation Oncology, and Pauline Funchain, MD, medical oncologist, in virtual tours of the radiation and infusion suites as well as other patient areas. Videos, panoramic images and other immersive media are available on Washington Post’s website.


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

October 18, 2023
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

August 31, 2023
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust